Search Results - "Lu, Xiang‐Ran"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    PD-L1 negatively regulates antifungal immunity by inhibiting neutrophil release from bone marrow by Yu, Yao, Wang, Rong-Rong, Miao, Nai-Jun, Tang, Jia-Jie, Zhang, Yun-Wei, Lu, Xiang-Ran, Yan, Pei-Yi, Wang, Jing, Jia, Xin-Ming

    Published in Nature communications (11-11-2022)
    “…Programmed death ligand 1 (PD-L1) has been shown to be inducibly expressed on neutrophils to suppress host immunity during polymicrobial sepsis, virus and…”
    Get full text
    Journal Article
  2. 2

    Functional characterization of 27 CYP3A4 variants on macitentan metabolism in vitro by Li, Ying‐hui, Lu, Xiangran, Lin, Qian‐meng, Huang, Huan‐le, Liang, Xiao‐long, Cai, Jian‐ping, Cui, Ju, Hu, Guo‐xin

    Published in Journal of pharmacy and pharmacology (01-11-2019)
    “…Objective Macitentan is a new choice for pulmonary hypertension treatment which is converted to active metabolite ACT132577 by human cytochrome P450 3A4. Human…”
    Get full text
    Journal Article
  3. 3

    Effects of 27 CYP3A4 protein variants on saxagliptin metabolism in vitro by liu, Qian, Ou‐Yang, Qiu‐Geng, Lin, Qian‐Meng, Lu, XiangRan, Ma, Ya‐Qing, Li, Ying‐Hui, Xu, Ren‐Ai, Lin, Dong‐dong, Hu, Guo‐Xin, Cai, Jian‐Ping

    Published in Fundamental & clinical pharmacology (01-02-2022)
    “…Saxagliptin is a dipeptidyl peptidase 4 (DPP‐4) inhibitor widely used in patients with type 2 diabetes. It can increase the amount of insulin after meals and…”
    Get full text
    Journal Article
  4. 4

    Characterization of Genetic Variation in CYP3A4 on the Metabolism of Cabozantinib in Vitro by Lin, Qian-meng, Li, Ying-hui, Lu, Xiang-ran, Wang, Ru, Pang, Ni-hong, Xu, Ren-ai, Cai, Jian-ping, Hu, Guo-xin

    Published in Chemical research in toxicology (19-08-2019)
    “…Cabozantinib is a multityrosine kinase inhibitor and has a wide range of applications in the clinic, whose metabolism is predominately dependent on CYP3A4…”
    Get full text
    Journal Article
  5. 5

    Enzymatic Activities of CYP3A4 Allelic Variants on Quinine 3-Hydroxylation In Vitro by Zhou, Xiao-Yang, Hu, Xiao-Xia, Wang, Chen-Chen, Lu, Xiang-Ran, Chen, Zhe, Liu, Qian, Hu, Guo-Xin, Cai, Jian-Ping

    Published in Frontiers in pharmacology (31-05-2019)
    “…Cytochrome P450 3A4 (CYP3A4) enzyme activity is known to show considerable ethnic heterogeneity and inter-individual differences, affecting the outcome of drug…”
    Get full text
    Journal Article
  6. 6

    Identification and Enzymatic Activity Evaluation of a Novel CYP2C9 Allelic Variant Discovered in a Patient by Zhou, Xiao-Yang, Lu, Xiang-Ran, Li, Ying-Hui, Ma, Ya-Qing, Zhao, Shi-Wen, Wang, Fang, Xu, Ren-Ai, Hu, Guo-Xin, Cai, Jian-Ping

    Published in Frontiers in pharmacology (11-02-2021)
    “…Warfarin is a widely prescribed anticoagulant but the doses required to attain the optimum therapeutic effect exhibit dramatic inter-individual variability…”
    Get full text
    Journal Article
  7. 7

    Determination and pharmacokinetic study of Enasidenib in rat plasma by UPLC–MS/MS by Pang, Ni-hong, Liu, Qian, Lu, Xiang-ran, Yang, Su-fen, Lin, Dong-dong, Hu, Guo-xin

    “…•There were no published reports of methods for detecting Enasidenib. In a word, this was the first paper to describe measurement of Enasidenib in rat…”
    Get full text
    Journal Article
  8. 8

    Amorphization of Ni_(61)Nb_(39) Alloy by Laser Surface Treatment by Zhong-xiang LU Ran LI Yan LI Tao ZHANG

    Published in 钢铁研究学报:英文版 (2016)
    “…The surface of Ni_(61)Nb_(39) crystalline ingot was treated by laser surface melting with different processing parameters.A fully amorphous layer with a…”
    Get full text
    Journal Article